Agios
Data Breaches, Cyber Attacks and Security Report

https://agios.com  ᛫  Biotech & Pharmaceuticals
Last updated November 12, 2019

About Agios

Company Overview

Agios Pharmaceuticals Inc. is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

Valuation

Employees

CEO

David Schenkein

Location

Data Breaches and Security News

Agios Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Agios is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Agios

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Agios's security performance with other companies